Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 2
1963 5
1964 8
1966 3
1967 1
1972 1
1976 2
1977 1
1978 1
1979 3
1980 2
1981 8
1982 5
1983 6
1984 3
1985 6
1986 13
1987 11
1988 8
1989 5
1990 4
1991 7
1992 5
1994 2
1995 3
1996 8
1997 4
1998 2
2000 2
2001 2
2002 2
2003 8
2004 9
2005 7
2006 7
2007 5
2008 3
2009 13
2010 5
2011 11
2012 15
2013 10
2014 11
2015 20
2016 26
2017 29
2018 29
2019 27
2020 39
2021 35
2022 39
2023 27
2024 25
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

479 results

Results by year

Filters applied: . Clear all
Page 1
Incidence of adverse events in minimally invasive vs open radical hysterectomy in early cervical cancer: results of a randomized controlled trial.
Obermair A, Asher R, Pareja R, Frumovitz M, Lopez A, Moretti-Marques R, Rendon G, Ribeiro R, Tsunoda A, Behan V, Buda A, Bernadini MQ, Zhao H, Vieira M, Walker J, Spirtos NM, Yao S, Chetty N, Zhu T, Isla D, Tamura M, Nicklin J, Robledo KP, Gebski V, Coleman RL, Salvo G, Ramirez PT. Obermair A, et al. Among authors: buda a. Am J Obstet Gynecol. 2020 Mar;222(3):249.e1-249.e10. doi: 10.1016/j.ajog.2019.09.036. Epub 2019 Oct 3. Am J Obstet Gynecol. 2020. PMID: 31586602 Free PMC article. Clinical Trial.
Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.
Ramirez PT, Frumovitz M, Pareja R, Lopez A, Vieira M, Ribeiro R, Buda A, Yan X, Shuzhong Y, Chetty N, Isla D, Tamura M, Zhu T, Robledo KP, Gebski V, Asher R, Behan V, Nicklin JL, Coleman RL, Obermair A. Ramirez PT, et al. Among authors: buda a. N Engl J Med. 2018 Nov 15;379(20):1895-1904. doi: 10.1056/NEJMoa1806395. Epub 2018 Oct 31. N Engl J Med. 2018. PMID: 30380365 Clinical Trial.
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial.
Cibula D, Kocian R, Plaikner A, Jarkovsky J, Klat J, Zapardiel I, Pilka R, Torne A, Sehnal B, Ostojich M, Petiz A, Sanchez OA, Presl J, Buda A, Raspagliesi F, Kascak P, van Lonkhuijzen L, Barahona M, Minar L, Blecharz P, Pakiz M, Wydra D, Snyman LC, Zalewski K, Zorrero C, Havelka P, Redecha M, Vinnytska A, Vergote I, Tingulstad S, Michal M, Kipp B, Slama J, Marnitz S, Bajsova S, Hernandez A, Fischerova D, Nemejcova K, Kohler C. Cibula D, et al. Among authors: buda a. Eur J Cancer. 2020 Sep;137:69-80. doi: 10.1016/j.ejca.2020.06.034. Epub 2020 Aug 1. Eur J Cancer. 2020. PMID: 32750501 Free article.
Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO).
Restaino S, Pellecchia G, Arcieri M, Bogani G, Taliento C, Greco P, Driul L, Chiantera V, Ercoli A, Fanfani F, Fagotti A, Ciavattini A, Scambia G, Vizzielli G; Gynecologic Oncology Group. Restaino S, et al. Cancers (Basel). 2024 Jul 15;16(14):2541. doi: 10.3390/cancers16142541. Cancers (Basel). 2024. PMID: 39061181 Free PMC article. Review.
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology.
Macaluso FS, Papi C, Orlando A, Festa S, Pugliese D, Bonovas S, Pansieri C, Piovani D, Fiorino G, Fantini MC, Caprioli F, Daperno M, Armuzzi A; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD); Working panel; Review panel. Macaluso FS, et al. Dig Liver Dis. 2023 Apr;55(4):442-453. doi: 10.1016/j.dld.2023.01.155. Epub 2023 Feb 13. Dig Liver Dis. 2023. PMID: 36792429 Free article.
Online medical education: A student survey.
Faria I, Moura CB, Graner M, Campos LN, Gerk A, Bittencourt MM, Cazumbá ML, Mishaly A, Buda AM, Truche P, Bowder AN, Botelho F, Carroll M, Mooney D, Naus A. Faria I, et al. Among authors: buda am. Clin Teach. 2023 Aug;20(4):e13582. doi: 10.1111/tct.13582. Epub 2023 May 21. Clin Teach. 2023. PMID: 37211433
Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
Chiorescu RM, Mocan M, Inceu AI, Buda AP, Blendea D, Vlaicu SI. Chiorescu RM, et al. Among authors: buda ap. Int J Mol Sci. 2022 Nov 7;23(21):13638. doi: 10.3390/ijms232113638. Int J Mol Sci. 2022. PMID: 36362423 Free PMC article. Review.
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology.
Macaluso FS, Orlando A, Papi C, Festa S, Pugliese D, Bonovas S, Pansieri C, Piovani D, Fiorino G, Fantini MC, Caprioli F, Daperno M, Armuzzi A; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD); Working panel; Review panel. Macaluso FS, et al. Dig Liver Dis. 2022 Apr;54(4):440-451. doi: 10.1016/j.dld.2022.01.127. Epub 2022 Feb 17. Dig Liver Dis. 2022. PMID: 35184989 Free article.
Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review.
Massano A, Bertin L, Zingone F, Buda A, Visaggi P, Bertani L, de Bortoli N, Fassan M, Scarpa M, Ruffolo C, Angriman I, Bezzio C, Casini V, Ribaldone DG, Savarino EV, Barberio B. Massano A, et al. Among authors: buda a. Cancers (Basel). 2023 Jul 27;15(15):3824. doi: 10.3390/cancers15153824. Cancers (Basel). 2023. PMID: 37568640 Free PMC article. Review.
479 results